RT Journal Article
SR Electronic
T1 Multimodal Data Acquisition at SARS-CoV-2 Drive Through Screening Centers: Setup Description and Experiences in Saarland, Germany
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.08.20240382
DO 10.1101/2020.12.08.20240382
A1 Philipp Flotho
A1 Mayur J. Bhamborae
A1 Tobias Grün
A1 Carlos Trenado
A1 David Thinnes
A1 Dominik Limbach
A1 Daniel J. Strauss
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.08.20240382.abstract
AB SARS-CoV-2 drive through screening centers (DTSC) have been implemented worldwide as a fast and secure way of mass screening. We use DTSCs as a platform for the acquisition of multimodal datasets that are needed for the development of remote screening methods. Our acquisition setup consists of an array of thermal, infrared and RGB cameras as well as microphones and we apply methods from computer vision and computer audition for the contactless estimation of physiological parameters. We have recorded a multimodal dataset of DTSC participants in Germany for the development of remote screening methods and symptom identification. Acquisition in the early stages of a pandemic and in regions with high infection rates can facilitate and speed up the identification of infection specific symptoms and large scale data acquisition at DTSC is possible without disturbing the flow of operation.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols http://www.snnu.uni-saarland.de/covid19/ Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics commission at the Aerztekammer des Saarlandes, ID No 90/20All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSee http://www.snnu.uni-saarland.de/covid19/ for information on data and source availability.